benjaminbertrand's library 73 articles Export Sort

Ordered by to_read.

Hide details

	On the relative safety of parenteral iron formulations [My Copy] Nephrol. Dial. Transplant., Vol. 19, No. 6. (1 June 2004), pp. 1571-1575. by Glenn M. Chertow, Phillip D. Mason, Odd Vaage-Nilsen, Jarl Ahlmen posted to fer by benjaminbertrand on 2009-06-21 14:47:32 as
	Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 22, No. 7. (1 April 2004), pp. 1301-1307. by M. Auerbach, H. Ballard, J. R. Trout, et al.M. McIlwain, A. Ackerman, H. Bahrain, S. Balan, L. Barker, J. Rana posted to fer by benjaminbertrand on 2009-06-21 14:36:43 as
	Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease. [My Copy] Journal of renal care, Vol. 35, No. 2. (June 2009), pp. 67-73. by S. Sinha, D. Y. Chiu, G. Peebles, et al.S. Kolakkat, E. Lamerton, S. Fenwick, P. A. Kalra posted to fer by benjaminbertrand on 2009-06-20 22:01:57 as
	Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 9, No. 4. (April 1998), pp. 655-663. by S. I. Patruta, R. Edlinger, G. Sunder-Plassmann, W. H. Hörl posted to fer by benjaminbertrand on 2009-07-04 21:41:28 as
	A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 16, No. 6. (June 2001), pp. 1239-1244. by M. Kosch, U. Bahner, H. Bettger, F. Matzkies, M. Teschner, R. M. Schaefer posted to fer by benjaminbertrand on 2009-07-02 19:45:53 as
	Labile iron: manifestations and clinical implications. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 15 Suppl 2 (December 2004) by D. B. Van Wyck posted to fer by benjaminbertrand on 2009-07-01 22:25:13 as
	Labile iron in parenteral iron formulations: a quantitative and comparative study. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 19, No. 3. (March 2004), pp. 561-565. by D. Van Wyck, J. Anderson, K. Johnson posted to fer by benjaminbertrand on 2009-07-01 22:22:53 as
	Structure, chemistry, and pharmacokinetics of intravenous iron agents. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 15 Suppl 2 (December 2004) by B. G. Danielson posted to fer by benjaminbertrand on 2009-07-01 16:05:34 as
	Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 33, No. 3. (March 1999), pp. 464-470. by G. Faich, J. Strobos posted to fer by benjaminbertrand on 2009-06-21 15:17:55 as
	Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. [My Copy] Kidney international, Vol. 73, No. 5. (March 2008), pp. 528-530. by M. Auerbach, K. Al Talib posted to fer by benjaminbertrand on 2009-06-21 15:14:09 as
	Acute injury with intravenous iron and concerns regarding long-term safety. [My Copy] Clinical journal of the American Society of Nephrology : CJASN, Vol. 1 Suppl 1 (September 2006) by K. Bishu, R. Agarwal posted to fer by benjaminbertrand on 2009-06-21 15:10:59 as
	Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. [My Copy] Kidney international, Vol. 63, No. 1. (January 2003), pp. 217-224. by D. W. Coyne, N. F. Adkinson, A. R. Nissenson, et al.S. Fishbane, R. Agarwal, J. W. Eschbach, B. Michael, V. Folkert, D. Batlle, J. R. Trout, N. Dahl, P. Myirski, J. Strobos, D. G. Warnock, posted to fer by benjaminbertrand on 2009-06-21 15:01:04 as
	The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. [My Copy] Seminars in dialysis, Vol. 13, No. 6. (c 2000), pp. 381-384. by S. Fishbane, E. A. Kowalski posted to fer by benjaminbertrand on 2009-06-21 14:57:58 as
	Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. [My Copy] Kidney international, Vol. 61, No. 5. (May 2002), pp. 1830-1839. by B. Michael, D. W. Coyne, S. Fishbane, et al.V. Folkert, R. Lynn, A. R. Nissenson, R. Agarwal, J. W. Eschbach, S. Z. Fadem, J. R. Trout, J. Strobos, D. G. Warnock, posted to fer by benjaminbertrand on 2009-06-21 14:56:38 as
	Parenteral iron therapy options. [My Copy] American journal of hematology, Vol. 76, No. 1. (May 2004), pp. 74-78. by S. B. Silverstein, G. M. Rodgers posted to fer by benjaminbertrand on 2009-06-21 14:51:53 as
	Safety issues with intravenous iron products in the management of anemia in chronic kidney disease. [My Copy] Clinical medicine & research, Vol. 6, No. 3-4. (December 2008), pp. 93-102. by A. Hayat posted to fer by benjaminbertrand on 2009-06-06 14:45:35 as
	Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury1 [My Copy] American Journal of Kidney Diseases, Vol. 40, No. 1. (July 2002), pp. 90-103. by R. Zager, A. Johnson, S. Hanson, H. Wasse posted to fer by benjaminbertrand on 2009-06-05 07:33:27 as
	Improving vaccination cold chain in the general practice setting. [My Copy] Australian family physician, Vol. 37, No. 10. (October 2008), pp. 892-896. by Sue L. Page, Arul Earnest, Hudson Birden, Rachelle Deaker, Chris Clark posted to cold_chain by benjaminbertrand on 2009-12-29 15:53:52 as
	Adult immunization services: Steps have to be done. [My Copy] Vaccine (27 November 2009) by Caroline Huot, Chantal Sauvageau, Geneviève Tremblay, Eve Dubé, Manale Ouakki posted to cold_chain by benjaminbertrand on 2009-12-29 14:48:06 as
	Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges. [My Copy] Influenza and other respiratory viruses, Vol. 3, No. 4. (July 2009), pp. 165-170. by Luc Hessel, European Vaccine Manufacturers (EVM) Influenza Working Group posted to cold_chain by benjaminbertrand on 2009-12-29 14:45:42 as
	Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer [My Copy] Journal of Gastroenterology and Hepatology, Vol. 24, No. 7. (2009), pp. 1236-1243. by Gul Javid, Showkat A. Zargar, Riyaz-u-saif, et al.Bashir A. Khan, Ghulam N. Yatoo, Altaf H. Shah, Ghulam M. Gulzar, Jaswinder S. Sodhi, Mushtaq A. Khan posted to ipp by benjaminbertrand on 2009-12-28 14:02:16 as
	Impact of compliance with proton pump inhibitors on NSAID treatment. [My Copy] The American journal of managed care, Vol. 15, No. 10. (October 2009), pp. 681-688. by Mei Sheng S. Duh, Antoine Gosselin, Roger Luo, Herve Lohoues, Barbara E. Lewis, Joseph A. Crawley posted to ipp by benjaminbertrand on 2009-11-23 09:40:34 as
	Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines. [My Copy] Digestion, Vol. 80, No. 4. (16 October 2009), pp. 226-234. by Sebastian Haag, Jane M. Andrews, Peter H. Katelaris, et al.Judith Gapasin, Jean Paul P. Galmiche, Richard Hunt, Peter Layer, Peter Malfertheiner, Gerald Holtmann posted to ipp by benjaminbertrand on 2009-11-23 09:37:11 as
	The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. [My Copy] Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, Vol. 12, No. 1. (January 2009), pp. 34-39. by Antoine Gosselin, Roger Luo, Herve Lohoues, et al.Edmond Toy, Barbara Lewis, Joseph Crawley, Mei Sheng S. Duh posted to ipp by benjaminbertrand on 2009-11-23 09:23:32 as
	A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. [My Copy] The New England journal of medicine, Vol. 361, No. 21. (19 November 2009), pp. 2019-2032. by Marc A. Pfeffer, Emmanuel A. Burdmann, Chao-Yin Y. Chen, et al.Mark E. Cooper, Dick de Zeeuw, Kai-Uwe U. Eckardt, Jan M. Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J. McMurray, Patrick Parfrey, Hans-Henrik H. Parving, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert Toto, TREAT Investigators posted to news by benjaminbertrand on 2009-11-19 09:39:49 as along with 1 person guhjy
	Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [My Copy] The New England journal of medicine (17 November 2009) by Stefan D. Anker, Josep Comin Colet, Gerasimos Filippatos, et al.Ronnie Willenheimer, Kenneth Dickstein, Helmut Drexler, Thomas F. Lüscher, Boris Bart, Waldemar Banasiak, Joanna Niegowska, Bridget-Anne A. Kirwan, Claudio Mori, Barbara von Eisenhart Rothe, Stuart J. Pocock, Philip A. Poole-Wilson, Piotr Ponikowski, the FAIR-HF Trial Investigators posted to fer by benjaminbertrand on 2009-11-19 09:29:07 as along with 2 people jaydoss cchand
	The role of psychosocial factors in peptic ulcer disease: Beyond Helicobacter pylori and NSAIDs [My Copy] Journal of Psychosomatic Research, Vol. 60, No. 4. (April 2006), pp. 407-412. by M. Jones posted to ipp by benjaminbertrand on 2009-11-04 15:51:18 as
	Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case–Control Study [My Copy] Gastroenterology, Vol. 133, No. 3. (September 2007), pp. 755-760. by D. Robertson, H. Larsson, S. Friis, L. Pedersen, J. Baron, H. Sorensen posted to ipp by benjaminbertrand on 2009-11-04 15:42:13 as
	Recent advances in proton pump inhibitors and management of acid-peptic disorders [My Copy] Bioorganic & Medicinal Chemistry, Vol. 15, No. 3. (01 February 2007), pp. 1181-1205. by Kishor S. Jain, Anamik K. Shah, Jitender Bariwal, et al.Suhas M. Shelke, Amol P. Kale, Jayshree R. Jagtap, Ashok V. Bhosale posted to ipp by benjaminbertrand on 2009-11-04 15:39:53 as
	Adéquation aux recommandations des prescriptions des inhibiteurs de la pompe à protons dans un service de médecine interne [My Copy] La Revue de Médecine Interne, Vol. 28, No. 2. (February 2007), pp. 86-93. by I. Marie, A. Moutot, A. Tharrasse, et al.M. Hellot, S. Robaday, F. Herve, H. Levesque posted to ipp by benjaminbertrand on 2009-11-04 15:10:11 as
	Prophylaxie de l’ulcère de stress en chirurgie: quelle attitude en pratique? Prevention of stress ulcer: a practical approach [My Copy] Journal de Chirurgie, Vol. 143, No. 4. (July 2006), pp. 226-229. by A. Champagne Danielou, S. Rohr posted to ipp by benjaminbertrand on 2009-11-04 15:01:41 as
	Non-NSAID non-H. pylori ulcer disease [My Copy] Best Practice & Research Clinical Gastroenterology, Vol. 23, No. 1. (February 2009), pp. 3-9. by Dorothy K. L. Chow, Joseph J. Y. Sung posted to ipp by benjaminbertrand on 2009-11-04 14:32:29 as
	Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit? [My Copy] Journal of Critical Care, Vol. 23, No. 4. (December 2008), pp. 513-518. by M. Beaulieu, D. Williamson, C. Sirois, J. Lachaine posted to ipp by benjaminbertrand on 2009-11-04 14:29:26 as
	Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: A comparison of gastric pH☆ [My Copy] Journal of Critical Care, Vol. 23, No. 3. (September 2008), pp. 416-421. by N. Tofil, K. Benner, M. Fuller, M. Winkler posted to ipp by benjaminbertrand on 2009-11-04 14:26:39 as
	Peptic ulcer disease [My Copy] The Lancet, Vol. 374, No. 9699. (30 October 2009), pp. 1449-1461. by Peter Malfertheiner, Francis K. L. Chan, Kenneth E. L. McColl posted to ipp by benjaminbertrand on 2009-11-04 14:10:21 as
	Overuse of stress ulcer prophylaxis in the critical care setting and beyond [My Copy] Journal of Critical Care (15 August 2009) by Christopher P. Farrell, Giancarlo Mercogliano, Catherine L. Kuntz posted to ipp by benjaminbertrand on 2009-11-04 14:01:28 as
	Stress ulcer prophylaxis in hospitalized patients not in intensive care units. [My Copy] American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, Vol. 64, No. 13. (1 July 2007), pp. 1396-1400. by Rebekah Arthur R. Grube, D. Byron May posted to ipp by benjaminbertrand on 2009-11-03 17:09:16 as
	Rational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions. [My Copy] World journal of gastroenterology : WJG, Vol. 13, No. 42. (14 November 2007), pp. 5618-5628. by Quan Zhou, Xiao-Feng F. Yan, Zhong-Miao M. Zhang, Wen-Sheng S. Pan, Su Zeng posted to ipp by benjaminbertrand on 2009-11-03 17:00:31 as
	Potential adverse effects of proton pump inhibitors. [My Copy] Current gastroenterology reports, Vol. 10, No. 3. (June 2008), pp. 208-214. by Gregory A. Coté, Colin W. Howden posted to ipp by benjaminbertrand on 2009-11-03 16:45:05 as
	Is there a dark side to long-term proton pump inhibitor therapy? [My Copy] American journal of therapeutics, Vol. 15, No. 6. (c 2008), pp. 536-542. by Thomas B. Nealis, Colin W. Howden posted to ipp by benjaminbertrand on 2009-11-03 16:34:02 as
	Long-term Safety Concerns with Proton Pump Inhibitors [My Copy] The American Journal of Medicine, Vol. 122, No. 10. (October 2009), pp. 896-903. by Tauseef Ali,, David e. i. l. Roberts,, William .. Tierney, posted to ipp by benjaminbertrand on 2009-11-03 16:05:48 as along with 1 person guhjy
	Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders. [My Copy] Drugs, Vol. 69, No. 4. (2009), pp. 435-448. by Marc Bardou, Janet Martin, Alan Barkun posted to ipp by benjaminbertrand on 2009-11-03 15:57:11 as
	Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected] [My Copy] The American journal of gastroenterology, Vol. 104 Suppl 2 (March 2009) by Joel J. Heidelbaugh, Kathleen L. Goldberg, John M. Inadomi posted to ipp by benjaminbertrand on 2009-11-03 15:54:01 as
	Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. [My Copy] Health Technol Assess., Vol. 11, No. 51. (December 2007), pp. 1-164. by G. I. Leontiadis, A. Sreedharan, S. Dorward, et al.P. Barton, B. Delaney, C. W. Howden, M. Orhewere, J. Gisbert, V. K. Sharma, A. Rostom, P. Moayyedi, D. Forman posted to ipp by benjaminbertrand on 2009-11-03 15:48:10 as
	Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. [My Copy] JAMA : the journal of the American Medical Association, Vol. 301, No. 9. (4 March 2009), pp. 937-944. by P. Michael Ho, Thomas M. Maddox, Li Wang, et al.Stephan D. Fihn, Robert L. Jesse, Eric D. Peterson, John S. Rumsfeld posted to ipp clopidogrel by benjaminbertrand on 2009-11-03 15:30:45 as
	Recommandations sur l'utilisation des antisecrétoires [My Copy] AFSSAPS (2007) by S. Afssap posted to ipp by benjaminbertrand on 2009-11-03 15:22:48 as
	Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 11, No. 3. (March 2000), pp. 530-538. by A. Besarab, N. Amin, M. Ahsan, et al.S. E. Vogel, G. Zazuwa, S. Frinak, J. J. Zazra, J. V. Anandan, A. Gupta posted to fer by benjaminbertrand on 2009-10-19 15:11:09 as
	An Indistinct Balance: The Safety and Efficacy of Parenteral IronTherapy [My Copy] J Am Soc Nephrol, Vol. 10, No. 9. (1 September 1999), pp. 2029-2043. by Anatole Besarab, Stanley Frinak, Jerry Yee posted to fer by benjaminbertrand on 2009-10-19 15:08:22 as
	Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients [My Copy] Nephrol. Dial. Transplant., Vol. 21, No. 10. (1 October 2006), pp. 2841-2845. by Daniela Schiesser, Isabelle Binet, Dimitrios Tsinalis, et al.Michael Dickenmann, Gerald Keusch, Markus Schmidli, Patrice M. Ambuhl, Liudmila Luthi, Rudolf P. Wuthrich posted to fer by benjaminbertrand on 2009-10-19 14:48:37 as
	Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. [My Copy] Circulation, Vol. 106, No. 17. (22 October 2002), pp. 2212-2217. by Tilman Drüeke, Véronique Witko-Sarsat, Ziad Massy, et al.Béatrice Descamps-Latscha, Alain P. Guerin, Sylvain J. Marchais, Valérie Gausson, Gérard M. London posted to fer by benjaminbertrand on 2009-10-16 00:08:44 as